EP2-ANTAGONIST

Patent europeic · EP3992176 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3992176
Numer da la dumonda
EP20832376
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
26-06-2020
Publitgà
04-05-2022
Concedì
27-08-2025
La protecziun finescha il pli tard
25-06-2040
Proxima taxa annuala scadenta
30-06-2026
Classas IPC
C07C 233/81 (2006.01)
A61K 31/192 (2006.01)
A61K 31/10 (2006.01)
A61P 1/04 (2006.01)
A61P 11/06 (2006.01)
A61P 13/10 (2006.01)
A61P 13/12 (2006.01)
A61P 15/00 (2006.01)
A61P 15/02 (2006.01)
A61P 17/02 (2006.01)
A61P 19/00 (2006.01)
C07C 327/48 (2006.01)
C07D 207/34 (2006.01)
Prioritad
JP 2019122077 28.06.2019
Dumonda PCT
PCT/JP2020/025187 26.06.2020
Publicaziun PCT
WO2020/262603 30.12.2020
Lingua da l’annunzia
giapunais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 08-07-2026

    Midada

    Published in Swissreg on 08.07.2026

  2. 27-08-2025

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 27.08.2025

Partidas

Possessur

Ono Pharmaceutical Co., Ltd.

ONO Pharmaceutical Co., Ltd.

1-5, Doshomachi 2-chome Chuo-ku, Osaka-shi, Osaka 541-8526, JP

Inventur

WATANABE, Akio

Mishima-gun, Osaka 618-8585, JP

YOSHIDA, Atsushi

Mishima-gun, Osaka 618-8585, JP

HIROOKA, Yasuo

Mishima-gun, Osaka 618-8585, JP

YANG, Michael G.

Princeton, New Jersey 08543, US

LI, Ning

Cambridge, Massachusetts 02140, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.